{"title_page": "Norethisterone acetate oxime", "text_new": "{{Drugbox\n| Verifiedfields = \n| Watchedfields = \n| verifiedrevid = \n| IUPAC_name = (1''S'',2''R'',5''E'',10''R'',11''S'',14''R'',15''S'')-14-ethynyl-5-(hydroxyimino)-15-methyltetracyclo[8.7.0.0<sup>2,7</sup>.0<sup>11,15</sup>]heptadec-6-en-14-yl acetate\n| image = Norethisterone acetate oxime.svg\n| width = 250px\n\n<!--Clinical data-->\n| tradename = \n| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->\n| pregnancy_US = <!-- A / B / C / D / X -->\n| pregnancy_category = \n| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->\n| legal_CA = \n| legal_UK = \n| legal_US = \n| legal_status = \n| routes_of_administration = [[Oral administration|By mouth]]\n| class = [[Progestogen]]; [[Progestogen ester]]\n\n<!--Pharmacokinetic data-->\n| bioavailability = \n| protein_bound = \n| metabolism = \n| elimination_half-life = \n| excretion = \n\n<!--Identifiers-->\n| CAS_number_Ref = \n| CAS_number = 20799-24-0\n| CAS_supplemental = \n| UNII_Ref = {{fdacite|correct|FDA}}\n| UNII = VFK4D40PMQ\n| ATC_prefix = \n| ATC_suffix = \n| PubChem = 91758682\n| DrugBank_Ref = \n| DrugBank = \n| ChemSpiderID_Ref = \n| ChemSpiderID =\n| synonyms = Norethindrone acetate oxime; ORF-5263; So-36; Norethisterone-3-oxime acetate; 17\u03b1-Ethynyl-19-nortestosterone 3-oxime 17\u03b2-acetate\n\n<!--Chemical data-->\n| C=22 | H=29 | N=1 | O=3\n| molecular_weight = 355.471 g/mol\n| SMILES = CC(=O)O[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=C/C(=N/O)/CC[C@H]34)C)C#C\n| StdInChI_Ref = \n| StdInChI = 1S/C22H29NO3/c1-4-22(26-14(2)24)12-10-20-19-7-5-15-13-16(23-25)6-8-17(15)18(19)9-11-21(20,22)3/h1,13,17-20,25H,5-12H2,2-3H3/b23-16+/t17-,18+,19+,20-,21-,22-/m0/s1\n| StdInChIKey_Ref = \n| StdInChIKey = SCTDPGXGNWEFNF-LQRGBYOBSA-N\n}}\n\n'''Norethisterone acetate oxime''' (developmental code names '''ORF-5263, So-36'''), or '''norethindrone acetate oxime''', is a [[steroid]]al [[progestin]] of the [[19-nortestosterone]] group which was developed as a [[emergency contraception|postcoital contraceptive]] but was never marketed.<ref name=\"Elks2014\">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA886|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=886\u2013}}</ref> It is the C3 [[oxime]] and C17\u03b2-[[acetate]] [[ester]] of [[norethisterone]].<ref name=\"Elks2014\"/>\n\n==See also==\n* [[List of progestogens]]\n* [[List of progestogen esters]]\n\n==References==\n{{Reflist}}\n\n{{Progesterone receptor modulators}}\n{{Androgen receptor modulators}}\n\n[[Category:Abandoned drugs]]\n[[Category:Acetate esters]]\n[[Category:Androgens and anabolic steroids]]\n[[Category:Estranes]]\n[[Category:Progestogen esters]]\n[[Category:Progestogens]]\n[[Category:Steroid oximes]]\n[[Category:Ketoximes]]\n\n{{Genito-urinary-drug-stub}}\n{{Steroid-stub}}\n", "text_old": "{{Drugbox\n| Verifiedfields = \n| Watchedfields = \n| verifiedrevid = \n| IUPAC_name = (1''S'',2''R'',5''E'',10''R'',11''S'',14''R'',15''S'')-14-ethynyl-5-(hydroxyimino)-15-methyltetracyclo[8.7.0.0<sup>2,7</sup>.0<sup>11,15</sup>]heptadec-6-en-14-yl acetate\n| image = Norethisterone acetate oxime.svg\n| width = 250px\n\n<!--Clinical data-->\n| tradename = \n| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->\n| pregnancy_US = <!-- A / B / C / D / X -->\n| pregnancy_category = \n| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->\n| legal_CA = \n| legal_UK = \n| legal_US = \n| legal_status = \n| routes_of_administration = [[Oral administration|By mouth]]\n| class = [[Progestogen]]; [[Progestogen ester]]\n\n<!--Pharmacokinetic data-->\n| bioavailability = \n| protein_bound = \n| metabolism = \n| elimination_half-life = \n| excretion = \n\n<!--Identifiers-->\n| CAS_number_Ref = \n| CAS_number = 20799-24-0\n| CAS_supplemental = \n| ATC_prefix = \n| ATC_suffix = \n| PubChem = 91758682\n| DrugBank_Ref = \n| DrugBank = \n| ChemSpiderID_Ref = \n| ChemSpiderID =\n| synonyms = Norethindrone acetate oxime; ORF-5263; So-36; Norethisterone-3-oxime acetate; 17\u03b1-Ethynyl-19-nortestosterone 3-oxime 17\u03b2-acetate\n\n<!--Chemical data-->\n| C=22 | H=29 | N=1 | O=3\n| molecular_weight = 355.471 g/mol\n| SMILES = CC(=O)O[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=C/C(=N/O)/CC[C@H]34)C)C#C\n| StdInChI_Ref = \n| StdInChI = 1S/C22H29NO3/c1-4-22(26-14(2)24)12-10-20-19-7-5-15-13-16(23-25)6-8-17(15)18(19)9-11-21(20,22)3/h1,13,17-20,25H,5-12H2,2-3H3/b23-16+/t17-,18+,19+,20-,21-,22-/m0/s1\n| StdInChIKey_Ref = \n| StdInChIKey = SCTDPGXGNWEFNF-LQRGBYOBSA-N\n}}\n\n'''Norethisterone acetate oxime''' (developmental code names '''ORF-5263, So-36'''), or '''norethindrone acetate oxime''', is a [[steroid]]al [[progestin]] of the [[19-nortestosterone]] group which was developed as a [[emergency contraception|postcoital contraceptive]] but was never marketed.<ref name=\"Elks2014\">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA886|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=886\u2013}}</ref> It is the C3 [[oxime]] and C17\u03b2-[[acetate]] [[ester]] of [[norethisterone]].<ref name=\"Elks2014\"/>\n\n==See also==\n* [[List of progestogens]]\n* [[List of progestogen esters]]\n\n==References==\n{{Reflist}}\n\n{{Progesterone receptor modulators}}\n{{Androgen receptor modulators}}\n\n[[Category:Abandoned drugs]]\n[[Category:Acetate esters]]\n[[Category:Androgens and anabolic steroids]]\n[[Category:Estranes]]\n[[Category:Progestogen esters]]\n[[Category:Progestogens]]\n[[Category:Steroid oximes]]\n[[Category:Ketoximes]]\n\n{{Genito-urinary-drug-stub}}\n{{Steroid-stub}}\n", "name_user": "Fswitzer4", "label": "safe", "comment": "added FDA UNII to drug box", "url_page": "//en.wikipedia.org/wiki/Norethisterone_acetate_oxime"}
